Telemark Asset Management LLC Sells 100,000 Shares of Aspen Aerogels, Inc. $ASPN

Telemark Asset Management LLC reduced its stake in Aspen Aerogels, Inc. (NYSE:ASPN) by 5.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,792,424 shares of the construction company’s stock after selling 100,000 shares during the period. Telemark Asset Management LLC owned about 2.18% of Aspen Aerogels worth $10,611,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ASPN. Envestnet Asset Management Inc. increased its stake in shares of Aspen Aerogels by 17.5% in the first quarter. Envestnet Asset Management Inc. now owns 55,511 shares of the construction company’s stock worth $355,000 after buying an additional 8,249 shares during the period. CWM LLC increased its position in shares of Aspen Aerogels by 2,137.9% in the first quarter. CWM LLC now owns 8,325 shares of the construction company’s stock valued at $53,000 after acquiring an additional 7,953 shares during the period. IFP Advisors Inc increased its position in shares of Aspen Aerogels by 28.9% in the first quarter. IFP Advisors Inc now owns 26,716 shares of the construction company’s stock valued at $171,000 after acquiring an additional 5,997 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Aspen Aerogels during the first quarter valued at about $203,000. Finally, Journey Strategic Wealth LLC boosted its holdings in shares of Aspen Aerogels by 17.3% during the first quarter. Journey Strategic Wealth LLC now owns 17,596 shares of the construction company’s stock worth $112,000 after purchasing an additional 2,596 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Trading Down 4.7%

ASPN opened at $2.94 on Friday. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. Aspen Aerogels, Inc. has a 52 week low of $2.93 and a 52 week high of $15.38. The stock has a market cap of $242.65 million, a PE ratio of -0.77 and a beta of 2.85. The business has a 50 day moving average of $6.69 and a 200-day moving average of $6.62.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Thursday, November 6th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The firm had revenue of $73.02 million during the quarter, compared to the consensus estimate of $73.42 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.Aspen Aerogels’s revenue for the quarter was down 37.8% compared to the same quarter last year. During the same quarter last year, the company posted ($0.17) EPS. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. Equities research analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Donald R. Young sold 56,845 shares of Aspen Aerogels stock in a transaction dated Thursday, November 13th. The shares were sold at an average price of $3.23, for a total transaction of $183,609.35. Following the completion of the transaction, the chief executive officer directly owned 494,011 shares of the company’s stock, valued at $1,595,655.53. This trade represents a 10.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 4.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on ASPN shares. Barclays reduced their price target on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a report on Friday, November 7th. Canaccord Genuity Group reduced their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Tuesday. Finally, Zacks Research cut shares of Aspen Aerogels from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, Aspen Aerogels presently has an average rating of “Hold” and a consensus target price of $12.67.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.